RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19

PURPOSE: Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several variants of concern have emerged including those in the United Kingdom, South Africa, and Brazil. SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Sean M., Lukhna, Kishal, Gorog, Diana A., Salama, Alan D., Castillo, Alejandro Rosell, Giesz, Sara, Golforoush, Pelin, Kalkhoran, Siavash Beikoghli, Lecour, Sandrine, Imamdin, Aqeela, do Carmo, Helison R. P., Bovi, Ticiane Gonçalez, Perroud, Mauricio W., Ntsekhe, Mpiko, Sposito, Andrei C., Yellon, Derek M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225459/
https://www.ncbi.nlm.nih.gov/pubmed/34169381
http://dx.doi.org/10.1007/s10557-021-07221-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225459/
https://www.ncbi.nlm.nih.gov/pubmed/34169381
http://dx.doi.org/10.1007/s10557-021-07221-y

Ejemplares similares